MedPath

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Not yet recruiting
Conditions
Optic Neuropathy, Ischemic
Anterior Ischemic Optic Neuropathy
Giant Cell Arteritis
Registration Number
NCT05749094
Lead Sponsor
Hopital du Sacre-Coeur de Montreal
Brief Summary

The Sonographic Assessment of the Optic Nerve Sheath in GCA (SONIC-GCA) study will: 1) assess the performance, in terms of sensitivity and specificity, of the optic nerve sheath diameter (ONSD) to detect new-onset, active GCA; 2) evaluate the intra- and interobserver reliability of ONSD measures; 3) establish if an association exists between the ONSD and the presence of GCA retinal findings; and 4) evaluate if the ONSD is a dynamic biomarker of GCA remission and relapse.

Detailed Description

SONIC-GCA is a prospective cohort and validation study conducted in centers of the Canadian Vasculitis Research Network (CanVasc).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean difference in ONSD on ultrasound between participants with and without GCABaseline
Secondary Outcome Measures
NameTimeMethod
Performance of the ONSD on ultrasound to identify GCA, in terms of sensitivity, specificity, positive and negative predictive values, and accuracy.Baseline
The Paired mean difference in ONSD during the follow-up period, based on changes in disease activity in GCA patients-from new-onset disease to clinical remission and from clinical remission to the first relapse (if any).Months 3 - 24

Trial Locations

Locations (1)

Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath